Individualized Lifetime Survival Benefit of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer

被引：0
|
作者：
Millen, Janelle-Cheri [1 ]
Chang, Shu-Ching [2 ]
Grunkemeier, Gary [3 ]
Nelson, Daniel [4 ]
Fischer, Trevan [5 ]
Morton, Donald L.
Goldfarb, Melanie [1 ]
机构：
[1] Providence St Johns Canc Inst, Providence, RI USA
[2] Providence Hlth & Serv, Providence, RI USA
[3] Providence Oregon Reg Shared Serv, Providence, OR USA
[4] William Beaumont Army Med Ctr, Ft Bliss, TX USA
[5] St Johns Canc Inst, Providence, RI USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E107
引用
收藏
页码：S210 / S210
页数：1
相关论文
共 50 条
  • [41] Adjuvant chemotherapy for stage II colon cancer: the time has come
    Mamounas, EP
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (08): : 725 - 729
  • [42] Microsatellite instability and adjuvant chemotherapy in stage II colon cancer.
    Koenig, Julie L.
    Lin, Albert Y.
    Pollom, Erqi L.
    Chang, Daniel Tandel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [43] Postoperative adjuvant chemotherapy improves survival in stage II colon cancer? A propensity score matching analysis
    Tsukamoto, Ryoichi
    Sugimoto, Kiichi
    Kawano, Shingo
    Niwa, Koichiro
    Ishiyama, Shun
    Kamiyama, Hirohiko
    Komiyama, Hiromitsu
    Takahashi, Makoto
    Kojima, Yutaka
    Goto, Michitoshi
    Tomiki, Yuichi
    Sakamoto, Kazuhiro
    CANCER RESEARCH, 2017, 77
  • [44] EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY ON SURVIVAL OF ELDERLY PATIENTS WITH HIGH RISK STAGE II COLON CANCER.
    Kim, M.
    Kim, C.
    Bae, S.
    Hur, H.
    Min, B.
    Baik, S.
    Lee, K.
    Kim, N.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (04) : E215 - E215
  • [45] Microsatellite Status and Adjuvant Chemotherapy in Patients with Stage II Colon Cancer
    Bachet, Jean-Baptiste
    Laurent-Puig, Pierre
    de Gramont, Aimery
    Andre, Thierry
    CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (03) : 148 - 157
  • [46] Dilemma of Stage II Colon Cancer and Decision Making for Adjuvant Chemotherapy
    Fang, Sandy H.
    Efron, Jonathan E.
    Berho, Mariana E.
    Wexner, Steven D.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (05) : 1056 - 1069
  • [47] Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
    O'Connor, Erin S.
    Greenblatt, David Yu
    LoConte, Noelle K.
    Gangnon, Ronald E.
    Liou, Jinn-Ing
    Heise, Charles P.
    Smith, Maureen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) : 3381 - 3388
  • [48] ADJUVANT CHEMOTHERAPY USE FOR STAGE II COLON CANCER IN MEDICARE POPULATION
    Jiao, X.
    Zhang, H.
    Barzi, A.
    VALUE IN HEALTH, 2018, 21 : S44 - S44
  • [49] Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer
    Nelson, Daniel W.
    Merritt, Clay
    Chang, Shu-Ching
    Grunkemeier, Gary
    Steele, Scott R.
    Goldfarb, Melanie
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (01) : 220 - 232
  • [50] Development of a Risk Score and Nomogram to Predict Individual Benefit Attained from the Addition of Adjuvant Chemotherapy in the Treatment of Stage II Colon Cancer
    Daniel W. Nelson
    Clay Merritt
    Shu-Ching Chang
    Gary Grunkemeier
    Scott R. Steele
    Melanie Goldfarb
    Journal of Gastrointestinal Surgery, 2021, 25 : 220 - 232
12345